当前位置:
X-MOL 学术
›
Cell Metab.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Of Mice and Men: NAD+ Boosting with Niacin Provides Hope for Mitochondrial Myopathy Patients.
Cell Metabolism ( IF 27.7 ) Pub Date : 2020-06-02 , DOI: 10.1016/j.cmet.2020.05.013 Eduardo Nunes Chini 1
中文翻译:
小鼠和人类:用烟酸促进 NAD+ 为线粒体肌病患者提供了希望。
更新日期:2020-06-02
Cell Metabolism ( IF 27.7 ) Pub Date : 2020-06-02 , DOI: 10.1016/j.cmet.2020.05.013 Eduardo Nunes Chini 1
Affiliation
In this issue of Cell Metabolism, Pirinen et al. (2020) show that disruption in NAD+ homeostasis is a key component of the pathogenesis of mitochondrial myopathy in humans that can be targeted by the administration of the NAD+ precursor niacin, identifying NAD+ boosting as a potential treatment for this devastating disease.
中文翻译:
小鼠和人类:用烟酸促进 NAD+ 为线粒体肌病患者提供了希望。
在本期细胞代谢中,Pirinen 等人。(2020) 表明,NAD +体内平衡的破坏是人类线粒体肌病发病机制的一个关键组成部分,可以通过施用 NAD +前体烟酸来靶向,确定 NAD +促进作为这种破坏性疾病的潜在治疗方法。